SCHEMBL2536068

SCHEMBL2536068

CC(C)(C)c1ccc(Oc2ccc(-c3ccc(OC(F)(F)F)cc3)cc2CCC(=O)O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 3/20 0.46
▸ SERPINE1 P05121 1/20 0.46
▸ SLC6A2 P23975 3/20 0.45
▸ SLC6A4 P31645 3/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ PPARD Q03181 5/20 0.44
▸ PPARG P37231 3/20 0.44
▸ PPARA Q07869 3/20 0.44
▸ NR1H4 Q96RI1 3/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ FFAR4 Q5NUL3 2/20 0.43
▸ TRPV1 Q8NER1 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ RXRG P48443 1/20 0.43
▸ GCGR P47871 2/20 0.42
▸ ADCY6 O43306 1/20 0.42
▸ ADCY3 O60266 1/20 0.42
▸ ADCY9 O60503 1/20 0.42
▸ ADCY5 O95622 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2537453 0.92 FFAR1 (0.48) FFAR1SLC6A2SLC6A4PPARDPPARG
SCHEMBL15434180 0.91 NPSR1 (0.47) FFAR1SERPINE1SLC6A2SLC6A4NPSR1
SCHEMBL15434111 0.91 NPSR1 (0.47) FFAR1SERPINE1SLC6A2SLC6A4NPSR1
SCHEMBL15434125 0.91 FFAR1 (0.47) FFAR1SLC6A2SLC6A4NPSR1PPARD
SCHEMBL2536390 0.88 FFAR4 (0.49) FFAR1SERPINE1NPSR1PPARDPPARG
SCHEMBL2535066 0.88 FFAR4 (0.49) FFAR1SERPINE1NPSR1PPARDPPARG
SCHEMBL2541537 0.87 SLC6A2 (0.49) FFAR1SLC6A2SLC6A4PPARDPPARG
SCHEMBL15434117 0.84 NPSR1 (0.49) FFAR1SLC6A2SLC6A4NPSR1PPARD
SCHEMBL15434130 0.83 FFAR1 (0.51) FFAR1SERPINE1NPSR1PPARDPPARG
SCHEMBL15434106 0.83 FFAR1 (0.48) FFAR1SLC6A2SLC6A4PPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044236-B2 Inhibitors against plasminogen activator inhibitor-1 (PAI-1); anticoagulants; 2-(aryl or aralkyloxy-)-5-(aryl)phenyl}acetic acid (or derivatives of propionic acid, propenoic acid, N-oxamic acid or 1H-tetrazol-5-yl); occlusion, stenosis; low molecular weight; gene expression inhibition INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2011-10-25 — — US disclosed
EP-2080751-A1 CARBOXYLIC ACID DERIVATIVE Institute of Medicinal Molecular Design, Inc. (JP) 2009-07-22 — — EP disclosed
US-20080275116-A1 Carboxilic acid derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2008-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275116-A1 Carboxilic acid derivatives SERPINE1, CTRL, SERPINC1 FFAR1 710/4885SERPINE1 1/4885SLC6A2 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback